SUN PHARMACEUTICAL INDUSTRIES
Quarterly Results Analysis [Sep2025]
SUN PHARMACEUTICAL INDUSTRIES Quarterly Results
| Consolidated | Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹14,478 Cr | ₹13,851 Cr | ₹12,959 Cr | ₹13,675 Cr | ₹13,291 Cr | ₹12,653 Cr | ₹11,983 Cr | ₹12,381 Cr |
| Expenses | ₹10,382 Cr | ₹9,779 Cr | ₹9,534 Cr | ₹9,666 Cr | ₹9,481 Cr | ₹9,045 Cr | ₹8,948 Cr | ₹9,028 Cr |
| Operating Income | ₹4,097 Cr | ₹4,073 Cr | ₹3,425 Cr | ₹4,009 Cr | ₹3,811 Cr | ₹3,608 Cr | ₹3,035 Cr | ₹3,352 Cr |
| Other Income | ₹900 Cr | ₹694 Cr | ₹904 Cr | ₹466 Cr | ₹482 Cr | ₹533 Cr | ₹606 Cr | ₹375 Cr |
| Interest | ₹100 Cr | ₹75 Cr | ₹49 Cr | ₹52 Cr | ₹69 Cr | ₹62 Cr | ₹74 Cr | ₹35 Cr |
| Depreciation | ₹730 Cr | ₹701 Cr | ₹664 Cr | ₹631 Cr | ₹626 Cr | ₹655 Cr | ₹650 Cr | ₹622 Cr |
| Profit Before Tax | ₹4,168 Cr | ₹3,173 Cr | ₹3,254 Cr | ₹3,476 Cr | ₹3,598 Cr | ₹3,424 Cr | ₹2,816 Cr | ₹3,000 Cr |
| Profit After Tax | ₹3,137 Cr | ₹2,303 Cr | ₹2,161 Cr | ₹2,918 Cr | ₹3,031 Cr | ₹2,871 Cr | ₹2,667 Cr | ₹2,568 Cr |
| EPS | ₹13.00 | ₹9.50 | ₹8.96 | ₹12.10 | ₹12.67 | ₹11.82 | ₹11.06 | ₹10.52 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SUN PHARMACEUTICAL INDUSTRIES | 2.8% | 6.7% | 2.8% |
| DIVIS LABORATORIES | 1.9% | -0.5% | 6.9% |
| CIPLA | 1.8% | -3.2% | 2.1% |
| TORRENT PHARMACEUTICALS | 0.1% | 3.4% | 15.8% |
| DR REDDYS LABORATORIES | 2.7% | 0.4% | 3.4% |
| MANKIND PHARMA | 1.4% | -7.9% | -13% |
| ZYDUS LIFESCIENCES | 1.7% | -5.9% | -1.6% |
| LUPIN | 4.1% | 6.4% | 1.8% |
| AUROBINDO PHARMA | 2.5% | 10% | 0.6% |
SUN PHARMACEUTICAL INDUSTRIES Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 4.53 % |
| Y-o-Y | 8.93 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Sep2025 | ₹14,478 Cr | 4.53 | |
| Jun2025 | ₹13,851 Cr | 6.89 | |
| Mar2025 | ₹12,959 Cr | -5.24 | |
| Dec2024 | ₹13,675 Cr | 2.89 | |
| Sep2024 | ₹13,291 Cr | 5.05 | |
| Jun2024 | ₹12,653 Cr | 5.59 | |
| Mar2024 | ₹11,983 Cr | -3.21 | |
| Dec2023 | ₹12,381 Cr | - | |
SUN PHARMACEUTICAL INDUSTRIES Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 0.59 % |
| Y-o-Y | 7.50 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Sep2025 | ₹4,097 Cr | 0.59 | |
| Jun2025 | ₹4,073 Cr | 18.91 | |
| Mar2025 | ₹3,425 Cr | -14.57 | |
| Dec2024 | ₹4,009 Cr | 5.20 | |
| Sep2024 | ₹3,811 Cr | 5.63 | |
| Jun2024 | ₹3,608 Cr | 18.86 | |
| Mar2024 | ₹3,035 Cr | -9.46 | |
| Dec2023 | ₹3,352 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | -3.78 % |
| Y-o-Y | -1.33 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Sep2025 | 28.29% | -3.78 | |
| Jun2025 | 29.4% | 11.24 | |
| Mar2025 | 26.43% | -9.86 | |
| Dec2024 | 29.32% | 2.27 | |
| Sep2024 | 28.67% | 0.56 | |
| Jun2024 | 28.51% | 12.55 | |
| Mar2024 | 25.33% | -6.46 | |
| Dec2023 | 27.08% | - | |
SUN PHARMACEUTICAL INDUSTRIES Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 36.24 % |
| Y-o-Y | 3.51 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Sep2025 | ₹3,137 Cr | 36.24 | |
| Jun2025 | ₹2,303 Cr | 6.57 | |
| Mar2025 | ₹2,161 Cr | -25.94 | |
| Dec2024 | ₹2,918 Cr | -3.73 | |
| Sep2024 | ₹3,031 Cr | 5.55 | |
| Jun2024 | ₹2,871 Cr | 7.67 | |
| Mar2024 | ₹2,667 Cr | 3.84 | |
| Dec2023 | ₹2,568 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | 30.39 % |
| Y-o-Y | -4.96 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Sep2025 | 21.67 % | 30.39 | |
| Jun2025 | 16.62 % | -0.30 | |
| Mar2025 | 16.67 % | -21.85 | |
| Dec2024 | 21.33 % | -6.45 | |
| Sep2024 | 22.8 % | 0.48 | |
| Jun2024 | 22.69 % | 1.98 | |
| Mar2024 | 22.25 % | 7.28 | |
| Dec2023 | 20.74 % | - | |
SUN PHARMACEUTICAL INDUSTRIES Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 36.84 % |
| Y-o-Y | 2.60 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Sep2025 | ₹13 | 36.84 | |
| Jun2025 | ₹9.5 | 6.03 | |
| Mar2025 | ₹8.96 | -25.95 | |
| Dec2024 | ₹12.1 | -4.50 | |
| Sep2024 | ₹12.67 | 7.19 | |
| Jun2024 | ₹11.82 | 6.87 | |
| Mar2024 | ₹11.06 | 5.13 | |
| Dec2023 | ₹10.52 | - | |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD